NicholasDavidGulatiMDPhD

Assistant Professor

Dr. Gulati is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York University School of MedicinePost-Doctoral Fellowship, 2020 - 2021
NYU Grossman School of MedicineResidency, Dermatology, 2018 - 2021
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2017 - 2018
Weill Cornell MedicineClass of 2017, MD
Rockefeller UniversityPhD, Biological Sciences, 2016
Columbia UniversityBA, 2008

PubMed

Relative risk of keloids in patients with chronic inflammatory skin disorders.
Raphaella Lambert, Hannah Verma, Grace Rabinowitz, Nicholas Gulati, Jonas A Adalsteinsson
JAAD International. 2025-04-01
SpotCheck: A skin cancer diagnostic accuracy study comparing teledermoscopy with and without electrical impedance spectroscopy to in-person dermatologist evaluation of...
Jenne P Ingrassia, Shirin Bajaj, Avani Kolla, Vivienne Li, Payal Shah
Journal of the American Academy of Dermatology. 2025-03-01
Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis.
David Garate, Christopher J Thang, Crystal T Chang, Shayan Owji, Trevor L Murphy
The Journal of Allergy and Clinical Immunology. in Practice. 2025-03-01

Dupilumab Associated with Significantly Lower Malignancy Risks in Atopic DermatitisDecember 20th, 2024
New Remote Tool Is Highly Accurate in Diagnosing MelanomaNovember 15th, 2024
Symptoms Resolve with Dupilumab in Patients with Drug ReactionsAugust 31st, 2023
Join now to see all